PAVmed (PAVM) Non-Current Deferred Tax Liability (2024)
PAVmed (PAVM) recorded quarterly Non-Current Deferred Tax Liability of $62.3 million in Q3 2024.
PAVmed (PAVM) Non-Current Deferred Tax Liability (2024) Analysis & Trends
PAVmed's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $62.3 million for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | PAVmed | 2.70 Mn | -10.47 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 10, 2024 | 62.30 Mn |
| Sep 10, 2024 | 62.30 Mn |